Page 61 - ஜான்ஸ் ஹாப்கின்ஸ் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA OKs first new ADHD drug in over a decade for children LINDA A. JOHNSON, Associated Press April 5, 2021 FacebookTwitterEmail This undated image provided by Supernus Pharmaceuticals in April 2021 shows bottles for different dosages of the drug Qelbree. On Friday, April 2, 2021, the U.S. Food and Drug Administration approved the medication for treating attention deficit hyperactivity disorder in children ages six through 17. (Supernus Pharmaceuticals via AP)AP U.S. regulators have approved the first new drug in over a decade for children with ADHD, which causes inattention, hyperactivity and impulsivity. The Food and Drug Administration late Friday OK’d Qelbree (KELL’-bree) for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that’s taken daily.

United statesLindaa johnsonDavidw goodmanJohns hopkins school of medicinePsychiatric associatesHealth science departmentSupernus pharmaceuticals of rockvilleSupernus pharmaceuticalsSuburban psychiatric associatesJohns hopkins schoolAssociated press healthScience departmentHoward hughes medical instituteNorth americaMc complete state nationalPremium entertainment